CCC
CTSO icon

Cable Car Capital’s Cytosorbents Corp CTSO Stock Holding History

Cable Car Capital’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$45.5K – 64
2024
Q4 		$45.5K Buy
+50,000
New +$49.1K ﹤0.01% 82

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cable Car Capital's CTSO Position: Q1 2025 in Review

Cable Car Capital sold out of Cytosorbents Corp (CTSO) in Q1 2025, closing a stake of 50,000 shares — an estimated $45.5K sold.

Cable Car Capital first reported a position in CTSO in Q4 2024 and held it in 1 quarter. The position peaked at $45.5K in Q4 2024. 49 funds tracked by Wall St. Rank hold CTSO as of Q1 2025.

  • Cable Car Capital reported no remaining Cytosorbents Corp position as of Q1 2025 after selling out during the quarter.
  • Cable Car Capital sold 50,000 Cytosorbents Corp shares in Q1 2025, an estimated $45.5K.
  • Cable Car Capital first reported a position in Cytosorbents Corp in Q4 2024 and held it in 1 quarter.
  • Cable Car Capital's Cytosorbents Corp position peaked at $45.5K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2025.

Based on Cable Car Capital's 13F filing for Q1 2025, filed 15 May 2025.